News
2d
News-Medical.Net on MSNCuproptosis offers new hope for treating inflammatory bowel disease and colorectal cancerCuproptosis represents a novel mechanism of cell death characterized by intracellular copper ion accumulation.
A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader ...
Purple Biotech presented promising NT219 data as a potential biomarker for colorectal cancer treatment at AACR 2025. Quiver AI Summary. Purple Biotech Ltd. has announced promising new data ...
9d
MedPage Today on MSNBiomarker Testing in Advanced Cancer Still Lags Behind Guideline RecommendationsOverall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% ...
Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...
9mon
News-Medical.Net on MSNMicrobial biomarkers identified in lupus and IBD offer pathways for targeted therapiesBy Pooja Toshniwal Paharia New research uncovers gut microbiome links to lupus and IBD, pointing to potential biomarkers and ...
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results